Hot Value Stocks To Buy For 2019

tags:SRCE,IEP,AUPH,

Unit Co. (NYSE:UNT) – Equities research analysts at SunTrust Banks lowered their Q3 2018 earnings estimates for shares of Unit in a report issued on Thursday, August 9th. SunTrust Banks analyst N. Dingmann now anticipates that the oil and gas company will post earnings per share of $0.17 for the quarter, down from their prior estimate of $0.18. SunTrust Banks currently has a “Hold” rating and a $26.00 price target on the stock. SunTrust Banks also issued estimates for Unit’s Q4 2018 earnings at $0.21 EPS.

Get Unit alerts:

Other equities analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Unit from a “strong sell” rating to a “hold” rating in a research report on Wednesday, June 20th. ValuEngine lowered shares of Unit from a “hold” rating to a “sell” rating in a research report on Thursday, May 3rd. Finally, Cowen set a $30.00 target price on shares of Unit and gave the stock a “hold” rating in a research report on Thursday, July 19th. Six analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Unit currently has a consensus rating of “Hold” and a consensus target price of $25.00.

Hot Value Stocks To Buy For 2019: 1st Source Corporation(SRCE)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on 1st Source (SRCE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on 1st Source (SRCE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  1st Source Co. (NASDAQ:SRCE) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $55.00.

• [By ]

  Currently, I like People's Utah Bancorp (Nasdaq: PUB), 1st Source Corporation (Nasdaq: SRCE), and East West Bancorp (Nasdaq: EWBC) as stocks likely to benefit in the small/regional sector.

• [By Max Byerly]

  1st Source (NASDAQ:SRCE)’s share price hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $56.13 and last traded at $55.94, with a volume of 100 shares changing hands. The stock had previously closed at $55.94.

Hot Value Stocks To Buy For 2019: Icahn Enterprises L.P.(IEP)

Advisors' Opinion:

• [By Brian Feroldi]

  While not every growth fund manager is worth following there are several that I greatly respect and can be a wonderful source of stock ideas. Here are a few of my favorite growth investors to follow:

  Pat Dorsey of Dorsey Asset Management: Dorsey was the director of equity research at Morningstar for more than a decade an authored two must-read books for growth investors: The Five Rules for Successful Stock Investing and The Little Book that Builds Wealth. Dorsey now runs his own asset management business and he makes concentrated bets in growth stocks that he believes will be able to compound shareholder wealth for years. Chuck Akre of Akre Capital Management: Akre ran the FBR Focus Fund from 1997 to 2009 and produced annualized returns of more than 12% during his tenure, which was far ahead of the 4.4% return of the S&P 500 over the same time frame. Akre launched his own mutual funds in 2009. His style is to buy growth stocks that are trading for value prices and he rarely sells. He also runs a concentrated portfolio. Carl Icahn of Icahn Capital Management: Long-term investors in Icahn's publicly traded investment vehicle Icahn Enterprises (NASDAQ:IEP) has enjoyed market-beating returns. Icahn's net worth has ballooned to more than $18 billion because of his knack for finding mispriced stocks. In recent years, he has become an activist investor who buys a meaningful position in a company and then shakes up its Board of Directors and management team in an effort to improve the business. While his fast-paced style isn't for everybody, I always enjoy looking at his portfolio to see what he has been buying or selling recently.

  There are also a plethora of websites out there that make easy to track and rank what notable growth investors are doing, including Whale Wisdom, TipRanks, and Guru Focus. Growth investors can visit any of these sites and quickly learn what many big-time money managers have been buying and selling in recent months to come up

• [By ]

  That being said, Icahn Enterprises (NYSE: IEP) has made the cut on at least three of four of these screens. And since we're always looking for positive attributes, that bodes well.

• [By Rich Duprey]

  Icahn Enterprises (NASDAQ:IEP) bought Tropicana in 2008 during the collapse of the financial markets. In 2010, Tropicana emerged from bankruptcy protection under a $200 million deal brokered by Icahn, which gave him control of eight casinos in Indiana, Louisiana, Mississippi, Nevada, Missouri, New Jersey, and Aruba. The Aruba resort is not included in the current deal, but will be sold at a later date.

• [By WWW.GURUFOCUS.COM]

  For the details of Carl Icahn's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn

  These are the top 5 holdings of Carl IcahnIcahn Enterprises LP (IEP) - 166,393,350 shares, 48.97% of the total portfolio. Shares added by 5.38%CVR Energy Inc (CVI) - 71,198,718 shares, 10.91% of the total portfolio. Herbalife Nutrition Ltd (HLF) - 35,227,904 shares, 7.84% of the total portfolio. Shares reduced by 22.99%Cheniere Energy Inc (LNG) - 23,680,490 shares, 6.39% of the total portfolio. Shares reduced by 27.54%Freeport-McMoRan

Hot Value Stocks To Buy For 2019: Aurinia Pharmaceuticals Inc(AUPH)

Advisors' Opinion:

• [By Brian Orelli]

  Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) jumped 11% in May, according to data provided by S&P Global Market Intelligence, after the biotech said it plans to test voclosporin, its only drug candidate, for additional diseases.

• [By Cory Renauer]

  Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), a biotechnology company developing an experimental new lupus therapy, rose 16.8% in September, according to data from S&P Global Market Intelligence. Analyst attention following an important step forward for the company's lead candidate pushed the stock higher.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Aurinia Pharmaceuticals (AUPH)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Isotechnika Pharma Inc. (NASDAQ:AUPH) (TSE:AUP) shares rose 6.7% during trading on Friday . The stock traded as high as $5.68 and last traded at $5.59. Approximately 54,590 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 429,596 shares. The stock had previously closed at $5.24.

• [By Ethan Ryder]

  Aurinia Pharmaceuticals (TSE:AUP) (NASDAQ:AUPH) issued its quarterly earnings data on Thursday. The company reported C($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of C($0.21) by C($0.04), reports. The firm had revenue of C$0.04 million during the quarter, compared to analyst estimates of C$0.07 million. Aurinia Pharmaceuticals had a negative return on equity of 30.41% and a negative net margin of 45,241.38%.